D. E. Shaw & Co., Inc. Seagen Inc. Call Options Transaction History

D. E. Shaw & Co., Inc.

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	SELL	$117.37 - $139.17 $1.17 Million - $1.39 Million	-10,000 Reduced 33.33%	20,000 $2.57 Million
Q3 2022 Nov 14, 2022	BUY	$135.27 - $180.11 $4.06 Million - $5.4 Million	30,000 New	30,000 $4.11 Million
Q4 2021 Feb 14, 2022	SELL	$142.57 - $190.86 $142,570 - $190,860	-1,000 Reduced 5.0%	19,000 $2.94 Million
Q1 2021 May 17, 2021	SELL	$137.51 - $190.8 $5.68 Million - $7.88 Million	-41,300 Reduced 67.37%	20,000 $2.78 Million
Q4 2020 Feb 16, 2021	BUY	$164.63 - $211.93 $10.1 Million - $13 Million	61,300 New	61,300 $10.7 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.